The report covers Blueprint Medicines' progress related to their environmental, social and governance (ESG) initiatives and strategy. The report highlights the company's progress in several key areas including patient access, employee engagement and responsible business practices. Specific highlights include the company's development of a diversity plan template for addressing ED&I efforts in clinical trials and the creation of a new clinical data platform to improve efficiency in clinical trial reporting and management. The report also outlines the company's commitment to sustainability and highlights specific initiatives to reduce their environmental impact such as a partnership with GreenLabs to recycle plastic items and participation in the Suit Up program to coach local high school students on job interviews.
Go back to company
Blueprint Medicines Corporation 2023 Sustainability Report
Issuing Company Blueprint Medicines Corporation
Report Type Sustainability Report
Report Language EN
Report Filesize 11.81 MB
No. of Pages 36 pages
Reporting periodJanuary 1 through December 31, 2023
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards SASB; UNSDGs
Materiality Assessmenttrue